Development and Multicenter Validation of a Novel Immune-Inflammation-Based Nomogram to Predict Survival in Western Resectable Gastric and Gastroesophageal Junction Adenocarcinoma (GEA): The NOMOGAST

Background. More than 50% of operable GEA relapse after curative-intent resection. We aimed at externally validating a nomogram to enable a more accurate estimate of individualized risk in resected GEA. Methods. Medical records of a training cohort (TC) and a validation cohort (VC) of patients under...

Descripción completa

Detalles Bibliográficos
Autores principales: Salati, Massimiliano, De Ruvo, Nicola, Giglio, Mariano Cesare, Sorrentino, Lorena, Esposito, Giuseppe, Fenocchi, Sara, Cucciarrè, Giovanni, Serra, Francesco, Rossi, Elena Giulia, Vittimberga, Giovanni, Radi, Giorgia, Solaini, Leonardo, Morgagni, Paolo, Grizzi, Giulia, Ratti, Margherita, Gelsomino, Fabio, Spallanzani, Andrea, Ghidini, Michele, Ercolani, Giorgio, Dominici, Massimo, Gelmini, Roberta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9500991/
https://www.ncbi.nlm.nih.gov/pubmed/36143086
http://dx.doi.org/10.3390/jcm11185439

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9500991/
https://www.ncbi.nlm.nih.gov/pubmed/36143086
http://dx.doi.org/10.3390/jcm11185439

Ejemplares similares